Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AHPINASDAQ:MOTSNASDAQ:NMRDNASDAQ:UTRS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAHPIAllied Healthcare Products$0.00$0.00▼$3.46$16K-2.3951,674 shsN/AMOTSMotus GI$0.00$0.00$0.00▼$0.19$2K0.284,610 shs126 shsNMRDNemaura Medical$0.00$0.00$0.00▼$0.06$4K0.637,852 shs501 shsUTRSMinerva Surgical$0.00$0.00▼$0.00$1K3.85350 shs25 shs10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAHPIAllied Healthcare Products0.00%0.00%0.00%0.00%-98.66%MOTSMotus GI0.00%0.00%+200.00%+200.00%-99.83%NMRDNemaura Medical0.00%0.00%0.00%-50.00%-99.79%UTRSMinerva Surgical0.00%0.00%0.00%0.00%-90.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAHPIAllied Healthcare ProductsN/AN/AN/AN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAHPIAllied Healthcare Products 0.00N/AN/AN/AMOTSMotus GI 0.00N/AN/AN/ANMRDNemaura Medical 0.00N/AN/AN/AUTRSMinerva Surgical 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAHPIAllied Healthcare Products$27.05M0.00N/AN/A$1.30 per share0.00MOTSMotus GI$319K0.01N/AN/A$1.74 per share0.00NMRDNemaura Medical$3.02K1.34N/AN/A($0.41) per share0.00UTRSMinerva Surgical$51.69M0.00N/AN/AN/ANaNCompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAHPIAllied Healthcare Products-$5.36M-$1.34N/AN/AN/AN/AN/AN/AN/AMOTSMotus GI-$12.87M-$15.64N/A∞N/AN/AN/AN/AN/ANMRDNemaura Medical-$14.14M-$0.39N/A∞N/AN/AN/AN/AN/AUTRSMinerva Surgical-$34.11MN/A0.00N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAHPIAllied Healthcare ProductsN/AN/AN/AN/AN/AMOTSMotus GIN/AN/AN/AN/AN/ANMRDNemaura MedicalN/AN/AN/AN/AN/AUTRSMinerva SurgicalN/AN/AN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAHPIAllied Healthcare Products4.15%MOTSMotus GI20.06%NMRDNemaura Medical4.41%UTRSMinerva SurgicalN/AInsider OwnershipCompanyInsider OwnershipAHPIAllied Healthcare Products5.10%MOTSMotus GI0.34%NMRDNemaura Medical40.42%UTRSMinerva Surgical8.50%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAHPIAllied Healthcare Products1504.01 million3.81 millionNot OptionableMOTSMotus GI305.77 million5.75 millionNot OptionableNMRDNemaura Medical4040.35 million24.04 millionNo DataUTRSMinerva Surgical1608.88 million8.12 millionNot OptionableNMRD, AHPI, MOTS, and UTRS HeadlinesRecent News About These CompaniesMinerva Surgical Inc.January 10, 2024 | thestreet.comWhy Is Minerva Surgical (UTRS) Stock Down 50% Today?December 18, 2023 | markets.businessinsider.comMinerva Surgical Inc UTRSDecember 17, 2023 | morningstar.comMinerva Surgical, Inc.: Minerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 14, 2023 | finanznachrichten.deMinerva Surgical GAAP EPS of -$0.81 misses by $0.27, revenue of $12M misses by $1.93MNovember 14, 2023 | msn.comMinerva Surgical Reports Third Quarter 2023 Financial ResultsNovember 13, 2023 | finance.yahoo.comAccelmed Files Transaction Statement on Schedule 13E-3 with Securities and Exchange CommissionSeptember 29, 2023 | finance.yahoo.comMinerva Surgical Inc (UTRS) Becoming More Attractive for InvestorsSeptember 27, 2023 | knoxdaily.comUTRS Shares Experience Surge in ValueAugust 25, 2023 | knoxdaily.comMinerva Surgical Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comMinerva Surgical, Inc. (UTRS) Reports Q2 Loss, Misses Revenue EstimatesAugust 3, 2023 | finance.yahoo.comInvestors in Minerva Surgical (NASDAQ:UTRS) from a year ago are still down 86%, even after 51% gain this past weekMay 25, 2023 | finance.yahoo.comPatent Grant Sends Healthcare Shares Soaring PremarketMay 24, 2023 | theglobeandmail.comWhy Minerva Surgical Shares Are Taking Off WednesdayMay 24, 2023 | msn.comWhy Is Minerva Surgical (UTRS) Stock Up 229% Today?May 24, 2023 | msn.comQ1 2023 Minerva Surgical Inc Earnings CallMay 3, 2023 | finance.yahoo.comMinerva Surgical Reports First Quarter 2023 Financial ResultsMay 2, 2023 | finance.yahoo.comModified Minerva orthosis proven helpful in pediatric patients following airway surgeryMay 2, 2023 | medicalxpress.comMinerva Surgical to Announce First Quarter 2023 Financial ResultsApril 18, 2023 | finance.yahoo.comMinerva Surgical, Inc. (NASDAQ:UTRS) Q4 2022 Earnings Call TranscriptMarch 24, 2023 | finance.yahoo.comNew MarketBeat Followers Over TimeNMRD, AHPI, MOTS, and UTRS Company DescriptionsAllied Healthcare Products NASDAQ:AHPIAllied Healthcare Products, Inc. engages in manufacturing respiratory products used in the health care industry in hospitals and alternate site settings, including sub-acute care facilities, home health care and emergency medical care. Its product line includes respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.Motus GI NASDAQ:MOTS$0.0003 0.00 (0.00%) As of 05/30/2025 12:47 PM EasternMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.Nemaura Medical NASDAQ:NMRD$0.0001 0.00 (0.00%) As of 09:30 AM EasternNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.Minerva Surgical NASDAQ:UTRSMinerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Buy The Dip in Okta, There’s Nothing Wrong With the Outlook Why SoundHound Could Be a Short Squeeze in the Making Why Schwab US Dividend Equity ETF Could Lead the Rotation Analysts Are Bullish on Marvell Stock Despite Amazon Deal Concern MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell 5 Reasons Costco Stock Will Hit New Highs This Year Ackman Takes a Swing at Amazon — Should You? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
